Posted by Michael Wonder on 08 May 2025
Brentuximab vedotin in combination with chemotherapy for the treatment of patients with stage 3 or 4 CD30 positive Hodgkin lymphoma
7 May 2025 - Brentuximab vedotin, when used in combination with doxorubicin hydrochloride, dacarbazine and vinblastine sulphate is recommended as an option for the first-line treatment of adults with stage 3 or 4 CD30 positive Hodgkin lymphoma.
It can only be used if Takeda provides it according to the commercial arrangement.
